WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech (Cayman) Inc., commonly referred to as WuXi AppTec, is a leading global pharmaceutical and biotechnology company headquartered in China. Founded in 2000, the company has established a strong presence in major operational regions, including North America and Europe, providing comprehensive services across the drug development lifecycle. Specialising in contract research, development, and manufacturing, WuXi AppTec offers unique solutions that streamline the process from discovery to commercialisation. Their core services encompass small molecule and biologics development, as well as advanced manufacturing capabilities, which set them apart in the competitive landscape. With a commitment to innovation and quality, WuXi AppTec has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical companies worldwide. Their dedication to enhancing drug development efficiency has earned them a notable reputation in the industry.
DitchCarbon Score
How does WuXi PharmaTech (Cayman) Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
WuXi PharmaTech (Cayman) Inc.'s score of 20 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
WuXi PharmaTech (Cayman) Inc.'s reported carbon emissions
In 2019, WuXi PharmaTech (Cayman) Inc. reported no specific carbon emissions data, including Scope 1, 2, or 3 emissions. The company has not disclosed any significant reduction targets or initiatives related to carbon emissions. As a result, there is limited information available regarding their climate commitments or strategies to mitigate environmental impact. The absence of detailed emissions data suggests that WuXi PharmaTech may still be developing its approach to sustainability and climate action within the pharmaceutical industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
WuXi PharmaTech (Cayman) Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
